Literature DB >> 2301606

Protection by benzamil against dysfunction and damage in rat myocardium after calcium depletion and repletion.

G N Pierce1, T G Maddaford, E A Kroeger, E J Cragoe.   

Abstract

Perfusion of the rat right ventricular wall muscle for 4 min with a Ca2(+)-free medium followed by perfusion with a Ca2(+)-containing solution resulted in a 42% recovery of developed tension, contracture, and a massive release of creatine phosphokinase (CPK) and lactate dehydrogenase (LDH) from the muscle. High concentrations (1-5 mM) of amiloride partially protected the ventricular wall from Ca2+ paradox-induced dysfunction. The inclusion of benzamil, an amiloride analogue, 2 min before and during the Ca2(+)-free perfusion period prevented contracture development, restored force development, and almost totally eliminated the release of CPK and LDH from the muscle. Contractile function was best protected by 10-50 microM benzamil. The results demonstrate the efficacy of benzamil as a protective agent against Ca2+ paradox-induced myocardial dysfunction and damage. In view of the known capacity of benzamil to block transsarcolemmal Na(+)-Ca2+ exchange, this study supports the involvement of elevated intracellular Na+ and a stimulation of Na(+)-Ca2+ exchange in this model of cardiac pathology.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2301606     DOI: 10.1152/ajpheart.1990.258.1.H17

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

Review 1.  Metabolic regulation of in vivo myocardial contractile function: multiparameter analysis.

Authors:  M D Osbakken
Journal:  Mol Cell Biochem       Date:  1994 Apr-May       Impact factor: 3.396

2.  Hoe 694, a new Na+/H+ exchange inhibitor and its effects in cardiac ischaemia.

Authors:  W Scholz; U Albus; H J Lang; W Linz; P A Martorana; H C Englert; B A Schölkens
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

Review 3.  Na+/H+ exchange and its inhibition in cardiac ischemia and reperfusion.

Authors:  W Scholz; U Albus
Journal:  Basic Res Cardiol       Date:  1993 Sep-Oct       Impact factor: 17.165

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.